Assessment of doxorubicin cardiac toxicity using gated 99 mTc-hexakis-2-methoxyisobutylisonitrile myocardial single photon emission computed tomography: Wall thickening and motion abnormalities can be an early sign of cardiac involvement

Circulation Journal

Volumn 76, Issue 5, 2012, Pages 1190-1196

  Wakabayashi, Hiroshi ^a   Taki, Junichi ^b   Inaki, Anri ^a   Sumiya, Hisashi ^b   Tsuchiya, Hiroyuki ^b   Kinuya, Seigo ^b  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cardiac toxicity; Doxorubicin; Gated 99 mTc MIBI SPECT; Left ventricular function

Indexed keywords

CAFFEINE; CISPLATIN; DOXORUBICIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ARTERIAL WALL THICKENING; ARTICLE; BONE TUMOR; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CONTINUOUS INFUSION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE WALL MOTION; HUMAN; MALE; REPRODUCIBILITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOFT TISSUE TUMOR;

ADOLESCENT; ADULT; ANTIBIOTICS, ANTINEOPLASTIC; BONE NEOPLASMS; CARDIOTOXINS; DOXORUBICIN; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; NITRILES; SOFT TISSUE NEOPLASMS; STROKE VOLUME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84860195219     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1174     Document Type: Article

References (24)

1. Tsuchiya H, Tomita K, Mori Y, Asada N, Morinaga T, Kitano S, et al. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma. Anticancer Res 1998; 18: 657-666.
2. Tsuchiya H, Tomita K, Mori Y, Asada N, Yamamoto N. Marginal excision for osteosarcoma with caffeine assisted chemotherapy. Clin Orthop Relat Res 1999; (358): 27-35.
3. Von Hoff DD, Layard MW, Basa P, Davis HL Jr, Von Hoff AL, Rozencweig M, et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 1979; 91: 710-717.
4. Kremer LC, van der Pal HJ, Offringa M, van Dalen EC, Voute PA. Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: A systematic review. Ann Oncol 2002; 13: 819-829.
5. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. Cancer 2003; 97: 2869-2879.
6. Minami M, Matsumoto S, Horiuchi H. Cardiovascular side-effects of modern cancer therapy. Circ J 2010; 74: 1779-1786.
7. Kremer LC, Caron HN. Anthracycline cardiotoxicity in children. N Engl J Med 2004; 351: 120-121.
8. Nousiainen T, Jantunen E, Vanninen E, Hartikainen J. Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients. Br J Cancer 2002; 86: 1697-1700.
9. Kapusta L, Groot-Loonen J, Thijssen JM, DeGraaf R, Daniels O. Regional cardiac wall motion abnormalities during and shortly after anthracyclines therapy. Med Pediatr Oncol 2003; 41: 426-435.
10. Taki J, Inaki A, Wakabayashi H, Sumiya H, Tsuchiya H, Zen Y, et al. Early prediction of histopathological tumor response to preoperative chemotherapy by Tc-99 m MIBI imaging in bone and soft tissue sarcomas. Clin Nucl Med 2010; 35: 154-159.
11. Taki J, Higuchi T, Sumiya H, Tsuchiya H, Minato H, Tomita K, et al. Prediction of final tumor response to preoperative chemotherapy by Tc-99 m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors: Comparison with Tl-201 imaging. J Orthop Res 2008; 26: 411-418.
12. Sawyer DB, Peng XY, Chen B, Pentassuglia L, Lim CC. Mechanisms of anthracycline cardiac injury: Can we identify strategies for cardioprotection? Prog Cardiovasc Dis 2010; 53: 105-113.
13. van Dalen EC, van der Pal HJ, Kok WE, Caron HN, Kremer LC. Clinical heart failure in a cohort of children treated with anthracyclines: A long-term follow-up study. Eur J Cancer 2006; 42: 3191-3198.
14. Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 1973; 32: 302-314.
15. Hortobagyi G. Adjuvant therapy for breast cancer. Annu Rev Med 2000; 51: 377-392.
16. Ganz WI, Sridhar KS, Forness TJ. Detection of early anthracycline cardiotoxicity by monitoring the peak filling rate. Am J Clin Oncol 1993; 16: 109-112.
17. Cottin Y, Touzery C, Coudert B, Gilles A, Walker P, Massing JL, et al. Impairment of diastolic function during short-term anthracycline chemotherapy. Br Heart J 1995; 73: 61-64.
18. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36: 2138-2147.
19. Germano G, Erel J, Lewin H, Kavanagh PB, Berman DS. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99 m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1997; 30: 1360-1367.
20. Heidendal GA, Bezemer PD, Koopman PA, den Hollander W, Teule GJ, van der Wall EE, et al. Reproducibility of ejection fraction measurements by gated equilibrium blood pool scintigraphy. Eur J Nucl Med 1983; 8: 467-470.
21. Yoshioka J, Hasegawa S, Yamaguchi H, Tokita N, Paul AK, Xiuli M, et al. Left ventricular volumes and ejection fraction calculated from quantitative electrocardiographic-gated 99 mTc-tetrofosmin myocardial SPECT. J Nucl Med 1999; 40: 1693-1698.
22. Ganame J, Claus P, Eyskens B, Uyttebroeck A, Renard M, D'Hooge J, et al. Acute cardiac functional and morphological changes after anthracycline infusions in children. Am J Cardiol 2007; 99: 974-977.
23. Dazzi H, Kaufmann K, Follath F. Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia: Analysis of the clinicopathological aspects of documented acute anthracycline-induced cardiotoxicity in patients treated for acute leukaemia at the University Hospital of Zurich, Switzerland, between 1990 and 1996. Ann Oncol 2001; 12: 963-966.
24. Kawahara M, Kagiyama H, Kanazawa Y, Tsuchiya H, Tomita K, Yokogawa K, et al. Rapid determination method of caffeine and application to monitoring of caffeine-assisted chemotherapy. Biopharm Drug Dispos 2004; 25: 61-67.